Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Nov 28 executedDec 2, 2025 disclosed
ADPT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Adaptive Biotechnologies Corp — Stock Option (right to buy)
Ticker
ADPT
Shares
3,750
Price per share
$0
Execution date (reported)
Nov 28, 2025
Owned after transaction
0 shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
4
What this establishes
Piskel Kyle filed this Form 4 reporting a option exercise of ADPT on Nov 28, 2025. It became public on Dec 2, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Piskel Kylecik:0001780662
Issuer
Adaptive Biotechnologies Corpcik:0001478320
Revision history · 0
No field has changed since this record was first ingested.
